![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JA Norman, J Ansell, GA Stone, LP Wennogle and JW Wasley
1,3-Dihydro-1-[1-[(4-methyl-4H,6H-pyrrolo[1,2-a][4,1]- benzoxazepin-4- yl)methyl]-4-piperidinyl]-2H-benzimidazol-2-o ne (1:1) maleate was synthesized in six steps from methyl anthranilate and designated CGS 9343B. CGS 9343B inhibited calmodulin-stimulated cAMP phosphodiesterase activity with an IC50 value of 3.3 microM. CGS 9343B was 3.8 times more potent than trifluoperazine (IC50 = 12.7 microM) as an inhibitor of calmodulin activity. CGS 9343B did not inhibit protein kinase C activity at concentrations up to 100 microM, whereas trifluoperazine inhibited protein kinase C activity with an IC50 value of 43.9 microM. CGS 9343B weakly displaced [3H]spiperone from postsynaptic dopamine receptors with an IC50 value of 4.8 microM while the value for trifluoperazine, a potent antipsychotic agent, was 0.018 microM. It is concluded that CGS 9343B is a novel, potent, and selective inhibitor of calmodulin activity. Unlike trifluoperazine, CGS 9343B does not inhibit protein kinase C activity and does not possess potential antidopaminergic activity.
This article has been cited by other articles:
|
|
 |
|
  W. Cao, K. M. Harnett, and V. E. Pricolo NK2 Receptor-Mediated Spontaneous Phasic Contractions in Normal and Ulcerative Colitis Human Sigmoid Colon J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1349 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Li, Z. Li, P. M. Howley, and D. B. Sacks E6AP and Calmodulin Reciprocally Regulate Estrogen Receptor Stability J. Biol. Chem., January 27, 2006; 281(4): 1978 - 1985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Cao, M. D. Vrees, F. M. Potenti, K. M. Harnett, C. Fiocchi, and V. E. Pricolo Interleukin 1{beta}-Induced Production of H2O2 Contributes to Reduced Sigmoid Colonic Circular Smooth Muscle Contractility in Ulcerative Colitis J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 60 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li, Z. Li, and D. B. Sacks Calmodulin Regulates the Transcriptional Activity of Estrogen Receptors. SELECTIVE INHIBITION OF CALMODULIN FUNCTION IN SUBCELLULAR COMPARTMENTS J. Biol. Chem., January 3, 2003; 278(2): 1195 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Briggs, Z. Li, and D. B. Sacks IQGAP1-mediated Stimulation of Transcriptional Co-activation by beta -Catenin Is Modulated by Calmodulin J. Biol. Chem., February 22, 2002; 277(9): 7453 - 7465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. D. Sohn, W. Cao, D.-C. Tang, J. T. Stull, J. R. Haeberle, C.-L. A. Wang, K. M. Harnett, J. Behar, and P. Biancani Myosin light chain kinase- and PKC-dependent contraction of LES and esophageal smooth muscle Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G467 - G478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Cao, Q. Chen, U. D. Sohn, N. Kim, M. T. Kirber, K. M. Harnett, J. Behar, and P. Biancani Ca2+-induced contraction of cat esophageal circular smooth muscle cells Am J Physiol Cell Physiol, April 1, 2001; 280(4): C980 - C992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Li, S. H. Kim, J. M. G. Higgins, M. B. Brenner, and D. B. Sacks IQGAP1 and Calmodulin Modulate E-cadherin Function J. Biol. Chem., December 31, 1999; 274(53): 37885 - 37892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Shashkin, A. Koshkin, D. Langley, J.-M. Ren, Håk. Westerblad, and A. Katz Effects of CGS 9343B (a Putative Calmodulin Antagonist) on Isolated Skeletal Muscle J. Biol. Chem., October 27, 1995; 270(43): 25613 - 25618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Li, J. L. Joyal, and D. B. Sacks Calmodulin Enhances the Stability of the Estrogen Receptor J. Biol. Chem., May 11, 2001; 276(20): 17354 - 17360. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
